| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 5.99M | — |
| Operating expense | — | — |
| Net income | -18.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALCLS.PA returned +12.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.8% |
| 1 year | +12.4% |
| 5 years | -77.2% |
| 10 years | -88.0% |
| All-time high | €40.90 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ALCLS.PA would be worth today ›No. Cellectis S.A. has not paid a dividend in the past 12 months.
Cellectis S.A. is part of the Healthcare sector.
Cellectis S.A. has a market cap of 283.98M EUR, based on the latest quote.
